S

Seegene Inc
KOSDAQ:096530

Watchlist Manager
Seegene Inc
KOSDAQ:096530
Watchlist
Price: 33 000 KRW -3.08% Market Closed
Market Cap: 1.7T KRW

Net Margin
Seegene Inc

2.4%
Current
10%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.4%
=
Net Income
10.6B
/
Revenue
440.3B

Net Margin Across Competitors

Seegene Inc
Glance View

Market Cap
1.7T KRW
Industry
Biotechnology

Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
37 046.83 KRW
Undervaluation 11%
Intrinsic Value
Price
S
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.4%
=
Net Income
10.6B
/
Revenue
440.3B
What is the Net Margin of Seegene Inc?

Based on Seegene Inc's most recent financial statements, the company has Net Margin of 2.4%.

Back to Top